News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,327 Results
Type
Article (87997)
Company Profile (825)
Press Release (781486)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233274)
Career Advice (4147)
Deals (39884)
Drug Delivery (151)
Drug Development (91427)
Employer Resources (205)
FDA (18395)
Job Trends (17428)
News (397946)
Policy (39970)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (148)
Alliances (56982)
ALS (181)
Alzheimer's disease (1794)
Antibody-drug conjugate (ADC) (348)
Approvals (18576)
Artificial intelligence (627)
Autoimmune disease (163)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (490)
Bladder cancer (163)
Brain cancer (65)
Breast cancer (667)
Cancer (5049)
Cardiovascular disease (444)
Career advice (3570)
Career pathing (41)
CAR-T (305)
CDC (59)
Celiac Disease (2)
Cell therapy (828)
Cervical cancer (37)
Clinical research (77042)
Collaboration (1823)
Company closure (5)
Compensation (1162)
Complete response letters (73)
COVID-19 (2993)
CRISPR (99)
C-suite (868)
Cystic fibrosis (154)
Data (6279)
Decentralized trials (2)
Denatured (72)
Depression (151)
Diabetes (535)
Diagnostics (7232)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (303)
Drug pricing (225)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100152)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135084)
Executive appointments (1033)
FDA (21583)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1558)
Gene editing (215)
Generative AI (64)
Gene therapy (672)
GLP-1 (1130)
Government (5441)
Grass and pollen (8)
Guidances (385)
Healthcare (20946)
HIV (61)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (292)
Immuno-oncology (59)
Indications (99)
Infectious disease (3280)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (249)
Interviews (816)
IPO (17955)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (69)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (16)
Lung cancer (679)
Lymphoma (379)
Machine learning (45)
Management (66)
Manufacturing (855)
MASH (174)
Medical device (15028)
Medtech (15080)
Mergers & acquisitions (22989)
Metabolic disorders (1401)
Multiple sclerosis (163)
NASH (23)
Neurodegenerative disease (355)
Neuropsychiatric disorders (99)
Neuroscience (3118)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (677)
Opinion (336)
Ovarian cancer (167)
Pain (212)
Pancreatic cancer (231)
Parkinson's disease (301)
Partnered (39)
Patents (511)
Patient recruitment (483)
Peanut (60)
People (66920)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23802)
Phase 2 (33429)
Phase 3 (25196)
Pipeline (5095)
Policy (337)
Postmarket research (3554)
Preclinical (10694)
Press Release (72)
Prostate cancer (247)
Psychedelics (55)
Radiopharmaceuticals (301)
Rare diseases (908)
Real estate (7440)
Recruiting (80)
Regulatory (29038)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (101)
The Weekly (122)
Vaccines (1150)
Venture capital (96)
Weight loss (465)
Women's health (88)
Worklife (21)
Date
Today (87)
Last 7 days (524)
Last 30 days (2601)
Last 365 days (32900)
2026 (2638)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (90)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51569)
Australia (9058)
California (11559)
Canada (3315)
China (1172)
Colorado (488)
Connecticut (501)
Delaware (348)
Europe (118471)
Florida (1691)
Georgia (372)
Hawaii (4)
Idaho (68)
Illinois (965)
India (69)
Indiana (544)
Iowa (24)
Japan (430)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1458)
Massachusetts (8504)
Michigan (358)
Minnesota (666)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3112)
New Mexico (33)
New York (3052)
North Carolina (1611)
North Dakota (10)
Northern California (5528)
Ohio (354)
Oklahoma (22)
Oregon (55)
Pennsylvania (2312)
Puerto Rico (23)
Rhode Island (50)
South America (1662)
South Carolina (65)
South Dakota (1)
Southern California (4464)
Tennessee (177)
Texas (1825)
United States (41695)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (974)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
There are 870,327 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Relay Therapeutics Announces Zovegalisib Granted Breakthrough Therapy Designation by U.S. FDA for PIK3CA-mutant, HR+/HER2- Advanced Breast Cancer
February 3, 2026
·
8 min read
Press Releases
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 3, 2026
·
1 min read
Press Releases
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
February 3, 2026
·
1 min read
Press Releases
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
February 3, 2026
·
4 min read
Press Releases
ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
February 3, 2026
·
8 min read
Press Releases
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer
February 3, 2026
·
8 min read
Press Releases
Invivyd Aligns with the U.S. FDA on LIBERTY, a Phase 3 Trial to Evaluate the Safety of VYD2311 Antibody Versus mRNA COVID Vaccine, and to Characterize the Safety and Immunology of Antibody and Vaccine Co-Administration
February 3, 2026
·
9 min read
Press Releases
Cartesian Therapeutics Announces New Employment Inducement Grants - February 3, 2026
February 3, 2026
·
1 min read
Obesity
Pfizer’s First Weight-Loss Data After Metsera Buy ‘Look Competitive’
With data from a mid-stage trial showing weight loss of up to 12.3% at 28 weeks in patients treated with PF’3944, “Pfizer is moving full speed into obesity clinical development,” BMO Capital Markets said Tuesday.
February 3, 2026
·
2 min read
·
Tristan Manalac
Antibody-drug conjugate (ADC)
Daiichi Sankyo Dumps Next-Gen ADC from Development Pipeline
DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload.
February 3, 2026
·
2 min read
·
Tristan Manalac
1 of 87,033
Next
